Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

MELAS SYNDROME

Clinical trials for MELAS SYNDROME explained in plain language.

Never miss a new study

Get alerted when new MELAS SYNDROME trials appear

Sign up with your email to follow new studies for MELAS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1
Sort by
  • New pill hopes to ease rare mitochondrial disease

    Disease control Recruiting now

    This study tests an oral drug called TTI-0102 in 12 people with MELAS, a rare genetic disorder that causes muscle weakness, strokes, and fatigue. Participants receive either the drug or a placebo for 6 months. Researchers will measure walking ability, fatigue, and quality of life…

    Matched conditions: MELAS SYNDROME

    Phase: PHASE2 • Sponsor: Thiogenesis Therapeutics, Inc. • Aim: Disease control

    Last updated Jun 26, 2026 14:36 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space